Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the management of lymphoid malignancies. However, it is still in its early phase and is facing many obstacles in solid tumors. Therapeutic challenges in solid tumor lead to tumor target diversification and drive new innovations for...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Medknow Publications
2022-07-01
|
| סדרה: | Hematology/Oncology and Stem Cell Therapy |
| נושאים: | |
| גישה מקוונת: | https://journals.lww.com/10.56875/2589-0646.1028 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|